Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from EBOS Group Limited ( (AU:EBO) ).
EBOS Group Limited announced the cessation of 5,417 performance rights due to unmet conditions, impacting its issued capital. This development may influence the company’s financial structuring and stakeholder interests, reflecting on its operational adjustments in the competitive healthcare and animal care markets.
More about EBOS Group Limited
EBOS Group Limited is a prominent entity in the healthcare and animal care sectors, providing a wide range of products and services across these industries. The company is known for its focus on delivering essential healthcare and pharmaceutical products, as well as veterinary supplies, to various markets.
YTD Price Performance: 0.99%
Average Trading Volume: 37,867
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$6.69B
See more data about EBO stock on TipRanks’ Stock Analysis page.